Trial Profile
A Double-Blind, Randomized, Placebo-Controlled Trial Evaluating The Safety And Efficacy Of Early Treatment With Eplerenone In Patients With Acute Myocardial Infarction
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Dec 2021
Price :
$35
*
At a glance
- Drugs Eplerenone (Primary)
- Indications Cardiovascular disorders; Myocardial infarction
- Focus Therapeutic Use
- Acronyms REMINDER
- Sponsors Pfizer
- 29 Apr 2014 Results published in the European Heart Journal.
- 11 Mar 2013 Results summarised in a media release from the American College of Cardiology.
- 11 Mar 2013 Results presented at the 62nd Annual Scientific Session of the American College of Cardiology. Additional information incorporated from slides presented at the conference.